Ondine Biomedical Inc (OBI)

Currency in GBP
13.75
0.00(0.00%)
Closed·
OBI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.7514.50
52 wk Range
7.5018.50
Key Statistics
Bid/Ask
13.00 / 14.00
Prev. Close
13.75
Open
14
Day's Range
13.75-14.5
52 wk Range
7.5-18.5
Volume
198.51K
Average Volume (3m)
588.9K
1-Year Change
3.7736%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OBI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Ondine Biomedical Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Ondine Biomedical Inc Earnings Call Summary for H2/2025

  • Ondine Biomedical posted 29% YoY revenue growth to CAD 2.6M, but reported CAD 29.5M net loss amid strategic focus on clinical trials.
  • R&D expenses more than doubled to CAD 21.2M, primarily funding LANTERN Phase III trial for U.S. market entry preparation.
  • Hospital customer base expanded 28% to 37 facilities; gross margin held at 61% despite increased research investments.
  • Company projects EPS of -$0.04 for FY2025-2026, with revenue forecast at $3.57 and $8.78 respectively as trials continue.
  • Stock declined 3.45% as investors weigh long-term clinical strategy against near-term profitability challenges and regulatory timeline risks.
Last Updated: 06/05/2026, 12:36 AM
Read Full Transcript

Earnings

Latest Release
Jun 04, 2026
EPS / Forecast
-0.03 / --
Revenue / Forecast
1.63M / --
EPS Revisions
Last 90 days

OBI Income Statement

Compare OBI to Peers and Sector

Metrics to compare
OBI
Peers
Sector
Relationship
P/E Ratio
−4.5x−3.0x−0.3x
PEG Ratio
−0.52−0.020.00
Price/Book
38.5x1.7x2.6x
Price / LTM Sales
50.7x11.9x2.9x
Upside (Analyst Target)
-225.2%56.7%
Fair Value Upside
Unlock−6.5%10.2%Unlock

Ondine Biomedical Inc., a life-sciences company, engages in the development of activated antimicrobial therapies for the prevention and treatment of infections in Canada and internationally. Its primary product is Steriwave, a non-invasive, nurse-administered treatment that eliminates harmful bacteria, viruses, and fungi from the nose. In addition, the company offers a pipeline of photodisinfection products for various indications, including chronic sinusitis, ventilator-associated pneumonia, burns and other indications. Ondine Biomedical Inc. was incorporated in 1996 and is headquartered in Vancouver, Canada.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
153.00M29.45%21.04M
Other Institutional Investors
117.04M22.53%16.09M
Public Companies & Retail Investors
249.51M48.02%34.31M
Total
519.55M100.00%71.44M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
M&G Investment Management Limited14.29%74,268,77510,212
M&G Investment Funds (3) - M&G Recovery Fund12.94%67,254,9019,248

People Also Watch

0.315
RMR
0.00%
135.00
PALMP
0.00%
77.00
ENSI
-3.75%

FAQ

What Is the Ondine Biomedical (OBI) Stock Price Today?

The Ondine Biomedical stock price today is 13.75 GBP.

What Stock Exchange Does Ondine Biomedical Trade On?

Ondine Biomedical is listed and trades on the London Stock Exchange.

What Is the Stock Symbol for Ondine Biomedical?

The stock symbol for Ondine Biomedical is "OBI."

What Is the Ondine Biomedical Market Cap?

As of today, Ondine Biomedical market cap is 71.44M GBP.

What Is Ondine Biomedical's Earnings Per Share (TTM)?

The Ondine Biomedical EPS (TTM) is -0.06.

From a Technical Analysis Perspective, Is OBI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Ondine Biomedical Stock Split?

Ondine Biomedical has split 0 times.

How Many Employees Does Ondine Biomedical Have?

Ondine Biomedical has 18 employees.

What is the current trading status of Ondine Biomedical (OBI)?

As of Jul 30, 2026, Ondine Biomedical (OBI) is trading at a price of 13.75 GBP, with a previous close of 13.75 GBP. The stock has fluctuated within a day range of 13.75 GBP to 14.50 GBP, while its 52-week range spans from 7.50 GBP to 18.50 GBP.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.